Use of Decision Aids in Clinical Encounters

Status:	Completed
Conditions:	Depression, Depression, High Cholesterol, Osteoporosis, Peripheral Vascular Disease
Therapuetic Areas:	Cardiology / Vascular Diseases, Psychiatry / Psychology, Rheumatology
Healthy:	No
Age Range:	18 - Any
Updated:	5/25/2016
Start Date:	September 2014
End Date:	May 2016

Patient-centered Dissemination of Evidence-based Medicine: Share EBM

The active strategy for dissemination and implementation of Share Evidence Based Medicine
(EBM) will yield greater reach of clinicians, be adopted by the practices more readily, and
a greater uptake of use amongst encounters will be seen.

The Institute for Clinical Systems Improvement (ICSI) is a nonprofit organization with
expertise in large-scale practice improvement at the state and national level. Largely
funded by health organizations in Minnesota, ICSI has a sustainable model to translate
evidence into practice, through clinical practice guidelines, shared decision making, and
practice redesign. A partnership between these two organizations (ICSI and Mayo Clinic) may
lead to a sustainable and innovative approach to the dissemination of evidence-based health
information at the point of care.

The objective of the current study is therefore to leverage the expertise of these two
organizations to compare the impact of an active to a passive dissemination and
implementation strategy of the ShareEBM toolkit. The aim of the study is to disseminate
evidence-based information through the use of decision aids during encounters. The overall
purpose of the qualitative evaluation is to understand why decision aids were used more or
less in certain practices and what factors contributed to or hindered this uptake.

Inclusion Criteria:

- Practices meeting the following criteria will be deemed eligible for the study if
they have:

1. At least 2 primary care clinicians committed to participate in the study.
Clinicians are defined as any healthcare professional providing patient care
(i.e., physicians, nurse practitioners, physician assistants, diabetes
educators)

2. A designated site champion and support staff that can provide the support needed
to conduct the study

3. An IRB approval from their institution or are covered under Mayo Clinic IRB

4. Leadership is committed to this research and has endorsed the study

- Any clinician caring for patients with a chronic condition and who has opportunities
to discuss medication management with their patients will be deemed eligible

Exclusion Criteria:

- Major barriers to participating or to providing informed consent

We found this trial at

sites

Ridgeview Medical Center

Delano, Minnesota 55328

from

Delano, MN